Palonosetron for prevention of acute and delayed nausea and vomiting induced by moderately emetogenic adjuvant folfox-4 regimen in colorectal cancer (CRC) patients: A phase II study of the Gruppo Oncologico dell' Italia Meridionale (GOIM)

Palonosetron is a very active antiemetic drug for the prevention of nausea and vomiting induced by folfox-4 regimen.